BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 19304323)

  • 21. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity.
    Johnson KD; Hsu AP; Ryu MJ; Wang J; Gao X; Boyer ME; Liu Y; Lee Y; Calvo KR; Keles S; Zhang J; Holland SM; Bresnick EH
    J Clin Invest; 2012 Oct; 122(10):3692-704. PubMed ID: 22996659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies.
    Bresnick EH; Katsumura KR; Lee HY; Johnson KD; Perkins AS
    Nucleic Acids Res; 2012 Jul; 40(13):5819-31. PubMed ID: 22492510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GATA2 mutations lead to MDS and AML.
    Hyde RK; Liu PP
    Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
    [No Abstract]   [Full Text] [Related]  

  • 24. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.
    Hahn CN; Chong CE; Carmichael CL; Wilkins EJ; Brautigan PJ; Li XC; Babic M; Lin M; Carmagnac A; Lee YK; Kok CH; Gagliardi L; Friend KL; Ekert PG; Butcher CM; Brown AL; Lewis ID; To LB; Timms AE; Storek J; Moore S; Altree M; Escher R; Bardy PG; Suthers GK; D'Andrea RJ; Horwitz MS; Scott HS
    Nat Genet; 2011 Sep; 43(10):1012-7. PubMed ID: 21892162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.
    Perrotti D; Harb JG
    Leuk Lymphoma; 2011 Feb; 52 Suppl 1(Suppl 1):30-44. PubMed ID: 21299458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
    Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
    Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia.
    Nakayama H; Ishimaru F; Avitahl N; Sezaki N; Fujii N; Nakase K; Ninomiya Y; Harashima A; Minowada J; Tsuchiyama J; Imajoh K; Tsubota T; Fukuda S; Sezaki T; Kojima K; Hara M; Takimoto H; Yorimitsu S; Takahashi I; Miyata A; Taniguchi S; Tokunaga Y; Gondo H; Niho Y; Harada M
    Cancer Res; 1999 Aug; 59(16):3931-4. PubMed ID: 10463586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
    Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
    Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and functional significance of osteocalcin splicing in disease progression of hematological malignancies.
    Wihlidal P; Varga F; Pfeilstöcker M; Karlic H
    Leuk Res; 2006 Oct; 30(10):1241-8. PubMed ID: 16387359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism.
    Zhang SJ; Shi JY; Li JY
    Leuk Res; 2009 Aug; 33(8):1141-3. PubMed ID: 19304323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 gene alterations in human hematological malignancies: a review.
    Soussi T; Jonveaux P
    Nouv Rev Fr Hematol (1978); 1991; 33(6):477-80. PubMed ID: 1818301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic myeloid leukaemia as a model of disease evolution in human cancer.
    Melo JV; Barnes DJ
    Nat Rev Cancer; 2007 Jun; 7(6):441-53. PubMed ID: 17522713
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.